SUO 2017: Retzius-sparing Robotic-assisted Laparoscopic Radical Prostatectomy: A Safe Oncologic Surgical Technique With Superior Continence Outcomes
Washington, DC (UroToday.com) Introduction: Conventional robotic-assisted laparoscopic radical prostatectomy (RALRP) is associated with significant side effects, including urinary incontinence. The authors of this study aimed to compare the peri-operative, oncologic, and functional outcomes of prostate cancer patients undergoing a Retzius-sparing RALRP (RS-RALRP) to those undergoing a conventional RALRP.
SUO 2017: Impact of Hospital Case Volume on Testicular Cancer Outcomes and Practice Patterns
Washington, DC (UroToday.com) Dr. Woldu and colleagues presented their results of a study assessing the impact of hospital case volume on testicular cancer outcomes. For other complex procedures, for example abdominal aortic aneurysm repair, Whipple procedure and radical cystectomy, there has been a call for centralization of these procedures to tertiary centers of excellence. Given the rarity of testicular germ cell tumors (TGCTs) and the complex aspects of management, the objective of this study was to evaluate the impact of hospital TGCT case volume on overall survival (OS) outcomes and practice patterns.
SUO 2017: Effect of Radiation Facility Ownership on Variation in Prostate Cancer Treatment and Spending
Washington, DC (UroToday.com) Differences in prostate cancer treatment arise from multiple patient and disease factors, as well as financial incentives from radiation facility ownership. These factors may serve as additional sources of variation. Dr. Tudor Borza and colleagues presented findings from their study assessing the effect of radiation facility ownership on variation in prostate cancer treatment and spending at the 18th Annual Meeting of the Society of Urologic Oncology.
SUO 2017: Prostate Cancer Presentation, Treatment Selection, And Outcomes Among Men With HIV/AIDS: A Contemporary Clinical Stage And Age-matched Analysis
Washington, DC (UroToday.com) Introduction: The clinical presentation, oncologic outcomes and optimal management of prostate cancer (PC) among human immunodeficiency virus-seropositive (HIV+) men is nod described well enough.
SUO 2017: Clinically Relevant Questions in the Surgical Management of Prostate Cancer
Washington, DC (UroToday.com) Professor Francesco Montorsi from Milan provided a comprehensive presentation discussing clinically relevant questions in the surgical management of prostate cancer.
SUO 2017: Healthcare Resource Utilization, Costs And Treatments In A US Population Of Non-metastatic And Metastatic Castration Resistant Prostate Cancer
Washington, DC (UroToday.com) Introduction: Health care resource use (HCRU) and costs among non-metastatic castration resistant prostate cancer (nmCRPC) patients who develop metastases have not been quantified among the insured US population.
SUO 2017: Impact Of USPSTF Recommendation On Rates Of Non-definitive Management In Low Risk Prostate Cancer Utilizing The National Cancer Database
Washington, DC (UroToday.com) Introduction: Since the 2011 U.S. Preventative Services Task Force (USPSTF) recommendation against prostate cancer (PCa) screening, there have been various modifications observed in the practice of urology.